↓ Skip to main content

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)

Overview of attention for article published in Arthritis Research & Therapy, April 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)
Published in
Arthritis Research & Therapy, April 2016
DOI 10.1186/s13075-016-0985-2
Pubmed ID
Authors

Ruediger B. Mueller, Michael Gengenbacher, Symi Richter, Jean Dudler, Burkhard Möller, Johannes von Kempis

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Unknown 86 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 15%
Student > Ph. D. Student 12 14%
Student > Master 12 14%
Researcher 8 9%
Other 5 6%
Other 10 11%
Unknown 27 31%
Readers by discipline Count As %
Medicine and Dentistry 23 26%
Nursing and Health Professions 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Psychology 5 6%
Agricultural and Biological Sciences 4 5%
Other 9 10%
Unknown 28 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2023.
All research outputs
#3,622,206
of 25,374,647 outputs
Outputs from Arthritis Research & Therapy
#819
of 3,381 outputs
Outputs of similar age
#56,147
of 315,339 outputs
Outputs of similar age from Arthritis Research & Therapy
#10
of 42 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 315,339 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.